Autoimmune retinopathy (AIR) is a rare inflammatory condition characterized by progressive visual loss, abnormalities in visual fields and electroretinographic exams, along with presence of circulating anti-retinal antibodies. There are two main forms of AIR: paraneoplastic AIR (pAIR) and presumed non-paraneoplastic AIR (npAIR). NpAIR is considered a diagnosis of exclusion, since it is typically made after other causes of retinopathy have been investigated and the absence of malignancy is confirmed. Work-up of a npAIR case is challenging since there are no standartizaded protocols for diagnosis and treatment. The treatment regimen may vary from case to case, and it can be best guided by a set of parameters including electrophysiological responses, visual outcomes, and presence of anti-retinal antibodies. The purpose of this review is to summarize the principal clinical features, investigation, and management of npAIR.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774818PMC
http://dx.doi.org/10.1080/13816810.2019.1650072DOI Listing

Publication Analysis

Top Keywords

anti-retinal antibodies
8
non-paraneoplastic retinopathy
4
retinopathy clinical
4
clinical challenges
4
challenges review
4
review autoimmune
4
autoimmune retinopathy
4
air
4
retinopathy air
4
air rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!